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Abstract
Objective:  To  determine  the  long-term  (>  3  years)  outcome  of  patients  suffering  from  sim-
ple snoring  or  non-severe  obstructive  sleep  apnea  syndrome  (OSAS)  treated  by  radiofrequency
ablation  of  the  soft  palate.
Study  design:  Observational  retrospective  study.
Setting:  Tertiary  care  university  hospital.
Subjects  and  methods:  Seventy-seven  subjects  were  included  between  1999  and  2006.
Twenty-seven  suffered  from  mild  or  moderate  OSAS.  All  patients  were  treated  by
radiofrequency-assisted  stiffening  of  the  soft  palate,  with  or  without  uvulectomy.  Snoring
(assessed  on  a  10  cm  visual  analog  scale  (VAS)),  marital  status,  presence  of  cardiovascular  risk
factors or  pathologies  and  follow-up  time  were  evaluated  by  postal  questionnaire.
Results: Mean  follow-up  time  was  6.3  ±  2.3  years.  Mean  snoring  intensity  decreased  signiﬁcantly
in the  immediate  postoperative  period  (8.1  ±  2.9  to  3.5  ±  2.2  cm  on  VAS).  Over  the  longer  term,
however, we  observed  a  signiﬁcant  increase  in  snoring  intensity  (5.7  ±  2.9  cm),  which  never-
theless remained  below  the  preoperative  values  (P  <  0.001).  Bed-partners  noticed  a  relapse
of snoring  in  92.7%  of  cases.  Nine  percent  of  couples  separated.  Hypertension  and  diabetes
were diagnosed  during  follow-up  in  12.1%  and  6.6%  of  the  subjects,  respectively.  A  majority  of
patients failed  to  undergo  repeat  polysomnography  or  further  treatment.
Conclusion:  Relapse  of  snoring  was  observed  in  nearly  all  patients  in  the  long  run,  although
intensity appears  to  remain  lower  than  preoperatively.  Most  patients  did  not  comply  with  the
follow-up  instructions  and  did  not  seek  other  forms  of  treatment  when  recurrence  occurred.
r  Ma© 2013  Published  by  Elsevie∗ Corresponding author. Tel.: +331 46252141; fax: +331 46252362.
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.  Introductionhronic  snoring  can  be  the  cause  of  a  signiﬁcant  social  dis-
omfort.  Obstructive  sleep  apnea  syndrome  (OSAS)  can  be
esponsible  for  excessive  daytime  sleepiness,  metabolic  dis-
rders  and  cardiovascular  diseases.
.
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Many  different  therapeutic  options  may  be  proposed
o  patients  suffering  from  simple  snoring  or  mild  to
oderate  OSAS.  Apart  from  sleep  hygiene,  dietary  coun-
eling,  mandibular  advancement  appliances,  continuous
ositive  airway  pressure  (CPAP),  surgery  can  be  offered.
our  techniques  targeting  the  soft  palate  can  be  per-
ormed:  uvulopalatopharyngoplasty  (often  combined  with
onsillectomy),  laser  treatment,  palatal  implants  and
adiofrequency-assisted  stiffening.  Despite  their  different
odes  of  action,  these  procedures  share  the  same  goals,
hich  are  to  reduce  the  vibration  of  the  soft  palate  and
ecrease  its  tissue  bulk.  Although  there  is  no  gold  standard
n  the  treatment  of  snoring,  radiofrequency  (RF)  has  become
ore  popular  in  the  last  decade  due  to  its  low  morbidity  and
he  fact  that  it  shows  similar  efﬁcacy  to  the  other  proce-
ures  [1].
The  short-term  efﬁcacy  of  this  treatment  and  the  per-
istence  in  time  of  its  effect  on  pharyngeal  obstruction  and
oft-tissue  vibration  may  impact  on  various  disease-related
arameters,  including  marital  status  and  cardiovascular
ariables  (particularly  when  OSAS  is  present).  Because  RF
s  a  very  simple  procedure,  some  patients  underestimate
he  severity  of  their  condition.  This  can  lead  to  failure  to
ttend  follow-up  visits  or  to  undergo  repeat  polysomno-
raphy  (PSG).  In  such  cases,  residual  disease  may  remain
ndiagnosed  and  therefore  untreated.
In  the  literature,  good  initial  results  have  been  docu-
ented  for  velopharyngeal  surgery  and  laser  procedures,
ut  their  efﬁcacy  has  been  shown  to  wane  over  time  [2—4].
Few  studies  have  assessed  the  mid-term  results  of  RF
tiffening,  but  there  also  appears  to  be  recurrence  of  symp-
oms  after  a  few  years  [5—8].  To  our  knowledge,  no  study
as  attempted  to  determine  the  long-term  effects  of  this
reatment.  Therefore,  the  main  goal  of  our  study  was  to
lucidate  clinical  outcome  in  a  population  of  patients  with
noring  or  mild/moderate  sleep  apnea  after  RF  treatment
f  the  soft  palate.
. Methods
rom  1998  to  2006,  228  patients  were  treated  with  RF  stiff-
ning  of  the  soft  palate  (with  or  without  shortening  of  the
vula)  in  our  department.  All  patients  were  simple  snorers
r  suffered  from  mild  to  moderate  OSAS.
Pre-therapeutic  investigation  included  history  focusing
n  marital  status,  medical  history  such  as  hypertension  and
iabetes,  and  the  Epworth  sleepiness  scale.  A  complete
tolaryngologic  physical  examination  was  performed  and
ody  mass  index  (BMI)  was  recorded.  All  subjects  under-
ent  polysomnography  (level  I,  II  or  III).  Treatment  options
ere  chosen  according  to  morphologic  parameters  and  the
pnea/hypopnea  index  (AHI)  and  all  suitable  options  were
roposed.  RF  was  offered  as  an  option,  especially  when  the
elar  area  was  considered  clinically  to  be  the  main  site  of
ibration  or  obstruction  on  physical  examination,  and  in  the
bsence  of  macroglossia  (stages  3  and  4  of  Friedman’s  clas-
iﬁcation),  obesity  (body  mass  index  >  30  kg/m2),  patient’s
omplaint  of  nasal  obstruction  or  AHI  >  20/h.  The  patient
ad  the  ﬁnal  choice.  The  procedures  were  performed  in  1  to
 sessions,  every  8  weeks,  until  the  bed-partner  considered
he  outcome  to  be  satisfactory.  RF  stiffening  was  associated
o
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o  resection  of  the  uvula  and/or  ablation  of  the  lower  part
f  the  soft  palate  when  these  were  considered  clinically  to
e  hypertrophic  or  elongated,  the  goal  being  to  treat  the
hole  subsite.  Ablative  procedures  were  performed  during
he  ﬁrst  session  for  some  patients  and  during  a  subsequent
ession  in  others.
Over  the  studied  period,  ﬁve  different  RF  generators
ere  used,  comprising  both  monopolar  and  bipolar  devices.
or  soft  palate  stiffening,  Select  Sutter  (bipolar),  Ellman
monopolar),  Somnus  (monopolar),  Coblator  (bipolar)  and
lympus  (bipolar)  were  used.  Uvulectomy  and  ablation
f  the  lower  velum  were  performed  using  a  diode  laser
Diomed)  or  an  RF  generator  (Select  Sutter  or  Olympus).
All  subjects  received  counseling  about  the  importance  of
 follow-up  visit  2  months  after  the  last  session.  For  patients
ith  known  OSAS,  repeat  polysomnography  was  prescribed
 to  6  months  after  treatment.
Patients  were  treated  according  to  indications  and  RF
echniques  derived  from  previous  studies  which  had  been
ubmitted  to  our  local  ethics  committee.  The  present  study
as  retrospective.  It  was  based  on  the  data  from  the
revious  studies  plus  a  long-term  evaluation  by  postal  ques-
ionnaire.  Therefore,  it  did  not  require  speciﬁc  approval
rom  our  local  ethics  committee.
.1.  Inclusion  criteria
ubjects  included  in  this  study  had  a  minimum  3  years’
ollow-up.  Each  patient  had  a  pre-therapeutic  snoring  inten-
ity  evaluation  performed  by  the  bed-partner  on  a  visual
nalog  scale  (VAS),  0  indicating  no  snoring  and  10  a  snore
ound  audible  in  another  room  or  justifying  sleeping  in  a
eparate  bedroom.  A  short-term  VAS  was  also  completed  2
onths  after  the  last  treatment  session.  For  OSAS  patients,
HI  between  5  and  20/h  was  used  as  a  selection  criterion.
noring  intensity  was  a  subjective  variable,  in  the  ear  of  the
ed-partner.  In  order  not  to  exacerbate  the  subjectivity  of
he  assessment,  especially  in  the  long  term,  we  only  used
noring  volume  as  assessment  criterion,  and  not  satisfaction.
.2.  Exclusion  criteria
atients  were  not  included  in  analysis  if  they  had  failed  to
nswer  the  short-  or  long-term  questionnaires  or  if  their  data
ere  not  interpretable.  Similarly,  subjects  who  had  changed
ed-partners  during  the  follow-up  period  were  not  included
n  the  calculation  of  the  recurrence  rate  of  snoring  and  of
he  long-term  snore  intensity.
.3.  Evaluation  of  long-term  outcome
 postal  questionnaire  was  sent  to  all  included  patients.
he  ﬁrst  section  of  the  survey  aimed  to  evaluate  the  evo-
ution  of  the  snoring  sound.  A  VAS  was  ﬁlled  out  by  the
ame  bed-partner  as  at  the  initial  evaluation.  If  the  patient
as  currently  receiving  a  treatment  (oral  appliance,  CPAP
r  other),  the  evaluation  had  to  be  undertaken  without
t.  Open  questions  were  asked  about  possible  recurrence
f  discomfort,  its  onset,  subjective  intensity  compared  to
he  pre-therapeutic  state  and  intermittent  or  permanent
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nature  and  whether  it  manifested  during  the  whole  night  or
only  a  part  of  it.  The  second  section  evaluated  the  impact
of  the  snoring  on  the  couple  (the  most  extreme  outcome
being  separation).  The  third  section  was  evaluation  of  day-
time  sleepiness  on  the  Epworth  sleepiness  scale.  Although
this  score  is  a  global  evaluation  of  daytime  sleepiness  and
not  directly  indicative  of  OSAS,  it  gave  us  a  hint  as  to  the
‘‘possible’’  onset  of  OSAS  in  a  simple  snorer  or  a  ‘‘possible’’
aggravation  of  a  previously  diagnosed  disease.  Section  four
measured  cardiovascular  risk  factors  such  as  hypertension,
diabetes  and  increase  in  BMI.  Section  ﬁve  targeted  the  post-
operative  follow-up:  attendance  for  the  post-therapeutic
PSG  and  follow-up  visits,  and  whether  or  not  the  patient  had
sought  further  treatment  in  case  of  symptom  recurrence.
2.4.  Outcome  measures
Snoring  intensity  was  evaluated  by  a  VAS  completed  by  the
bed-partner  before  and  shortly  after  treatment  and  at  the
time  of  the  postal  survey.  Three  groups  were  formed  accord-
ing  to  the  scores  on  the  short-  and  long-term  post-treatment
VASs:  improvement,  stabilization  and  aggravation.  We  iden-
tiﬁed,  beforehand,  4  factors  that  could  possibly  inﬂuence
snoring  aggravation  over  time:  the  magnitude  of  the  ini-
tial  reduction  in  sound  intensity,  BMI  variations,  the  type
of  procedure  performed  (with  or  without  uvulectomy)  and
an  associated  diagnosis  of  OSAS.
2.5.  Statistical  analysis
The  short-  and  long-term  values  of  the  variables  were  com-
pared  using  a  paired  Student  t  test.  For  proportions,  Chi2
tests  were  performed  to  compare  means,  and  a  one-way
Anova  for  repeated  measures  was  used  to  compare  the  VAS
scores.  When  a  signiﬁcant  difference  was  observed,  bilat-
eral  comparisons  were  performed  by  post-hoc  analysis  by
Fisher’s  exact  test.  Values  of  P  less  than  0.05  were  consid-
ered  statistically  signiﬁcant.  Statistical  tests  were  run  using
the  StatView  5  package  (SAS  Institute,  Grenoble,  France).
3. Results
3.1.  Study  population
Two  hundred  and  twenty-eight  patients  underwent  soft
palate  RF  treatment  for  snoring.  Eighty-three  patients  did
not  have  complete  (pre-  and  postoperative)  snoring  evalua-
tion  and  22  patients  had  an  apnea-hypopnea  index  >  20/h.
Overall,  123  patients  met  the  inclusion  criteria  and
were  sent  the  postal  survey.  Forty-three  failed  to  return
the  questionnaire  (including  28  who  had  moved  during  the
follow-up  period).  Three  questionnaires  were  not  ﬁlled
out  correctly.  No  statistical  difference  was  found  between
responders  and  non-responders  to  the  questionnaires  for
age  (P  =  0.32),  sex  (P  =  0.97),  BMI  (P  =  0.48),  associated
uvulectomy  (P  =  0.29),  pre-  and  postoperative  snore  inten-
sity  (P  =  0.09  and  P  =  0.98  respectively)  and  AHI  (P  =  0.27).
Overall,  77  patients  were  included  in  the  analysis.  All  were
treated  between  1998  and  2006.  Fifty  subjects  were  simple
snorers  and  27  suffered  from  mild  or  moderate  OSAS  (AHI
3
N
p29
 2  0/h).  The  cohort  comprised  59  males  and  18  females.
he  mean  age  of  the  study  population  at  the  ﬁrst  treatment
ession  was  52.2  ±  10.9  years.  It  was  59.4  ±  11.2  years  at
he  time  of  completion  of  the  survey.  Mean  follow-up  time
as  6.3  ±  2.3  years  (range,  3  to  11  years).
Patients  were  treated  with  RF  stiffening  either  alone  or
ombined  with  uvulectomy.  Among  patients  who  had  stiff-
ning  alone  (n  =  34),  10  had  only  a  single  session  while  21
ad  two  and  3  had  three  sessions.  Among  patients  who  also
ad  uvulectomy  (n  =  43),  4  were  treated  in  a  single  session
hile  7  had  two  sessions  and  32  received  three  sessions.
Data  regarding  weight  change  was  available  for  73
atients.  No  signiﬁcant  difference  was  found  between
re-therapeutic  and  long-term  mean  BMI  (respectively
4.7  kg/m2 and  25.3  kg/m2,  P  =  0.19).
.2.  Snoring
ere  excluded  from  this  analysis  all  subjects  who  had
hanged  bed-partners  during  the  follow-up  period  (n  =  10)
r  for  whom  long-term  snoring  intensity  was  not  properly
ocumented  on  the  VAS  (n  =  9).  Overall,  58  patients  could
e  evaluated.  Mean  age  was  58.9  ±  11.3  years.  Mean  AHI
as  9  ±  6/h.  The  mean  follow-up  time  for  this  subgroup  was
 ±  2.3  years.  Thirty-nine  patients  were  simple  snorers  while
9  suffered  from  OSAS.
According  to  most  bed-partners  (92.7%),  snoring  recurred
t  some  point  during  the  follow-up  period.  The  relapse
ccurred  less  than  6  months  after  treatment  for  39  subjects
67.2%),  between  6  and  12  months  for  8  (15.7%)  and  between
2  and  24  months  for  8  patients  (15.7%).  Snoring  was  consid-
red  to  be  continuous  over  the  entire  night  in  29.2%  of  the
ases.  It  was  present  every  single  night  in  76%  of  the  cases
nd  periodic  for  24%.
Snoring  sound  intensity  was  assessed  on  the  VAS.  We
ound  a  signiﬁcant  difference  between  the  preoperative
mean  VAS  =  8.1  ±  1.5)  and  immediate  postoperative  scores
mean  VAS  =  3.5  ±  2.2)  (P  <  0.0001).  A  signiﬁcant  increase
as  found  between  the  short-  and  long-term  postopera-
ive  scores  (mean  VAS  =  5.7  ±  2.9)  (P  <  0.0001).  However,  the
ong-term  VAS  scores  remained  signiﬁcantly  lower  than  the
reoperative  values  (P  <  0.001).  Twenty-seven  percent  of
he  bed-partners  reported  a  long-term  VAS  score  lower
han  3.
Most  bed-partners  (65.5%)  reported  an  increase  in  snore
ound  intensity  over  time  after  treatment;  stable  or  reduced
noring  volume  was  noted  in  equal  numbers  of  subjects
17.2%).  Among  patients  who  worsened,  47.3%  showed  an
ncrease  of  3  points  or  more  on  the  VAS.  Four  variables  were
hought  to  be  related  to  snoring  recurrence  (Table  1).  Of
hese,  the  two  most  signiﬁcant  were  a  greater  decrease
etween  the  pre-  and  postoperative  VAS  scores,  and  conser-
ation  of  the  uvula.  The  role  of  the  number  of  treatment
essions  could  not  be  evaluated  because  of  the  heterogene-
ty  of  the  groups,  with  very  few  patients  with  1  or  3  sessions..3.  Conjugal  status
ine  percent  of  the  couples  separated  during  the  follow-up
eriod.
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Table  1  Factors  studied  to  evaluate  their  inﬂuence  on  long-term  variation  in  snoring.
Snoring
improved  in  LT
n =  10
Snoring  stable
in LT
n =  10
Snoring
worsened  in  LT
n =  38
P
RF  ST  results  =  mean  differential  VAS  score  2.6  4  5.2  0.03
ST versus  initial  preoperative  VAS  7.2  ±  1.9  7.8  ±  1.8  8.4  ±  1.2  0.19
Change in  BMI  (kg/m2)  LT  versus  initial  +0.03  —0.54  +0.59  0.08
Associating uvulectomy  (%  patients  with  RF  +  cut)  90  50  47.4  0.002
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RF: radiofrequency; ST: short term; LT: long term; VAS: visual ana
aytime  sleepiness
he  mean  Epworth  score  was  signiﬁcantly  higher  pre-
peratively  (7.8  ±  4.6)  compared  with  the  immediate
ostoperative  values  (6.3  ±  4.2,  P  =  0.0005).  No  signiﬁcant
ifference  was  found  between  the  short  and  long-term
7.2  ±  4.7)  postoperative  periods  (P  =  0.069),  or  between  the
reoperative  and  long-term  values  (P  =  0.22).
.4.  Cardiovascular  risk
.4.1.  Weight
or  this  analysis,  patients  were  separated  into  three  groups:
eight  loss,  stable  weight  and  weight  gain.  Eighteen  sub-
ects  (24.6%)  lost  weight  during  the  follow-up  period  (mean
.6  kg,  BMI  decreased  from  24.1  to  22.5  kg/m2,  P  =  0.0002).
wenty-ﬁve  (34.2%)  did  not  show  any  signiﬁcant  weight
hange  (mean  BMI  24.7  kg/m2).  Thirty-four  patients  (46.5%)
ained  weight  (mean  4.7  kg,  BMI  increased  from  25.2  to
6.8  kg/m2,  P  <  0.0001).
.4.2.  Blood  pressure  and  diabetes
efore  treatment,  3  patients  suffered  from  arterial  hyper-
ension  (4.1%).  Two  of  these  patients  also  suffered  from
SAS.  Two  patients  suffered  from  diabetes  (2.7%);  they  were
oth  diagnosed  with  OSAS.
At  the  long-term  follow-up,  hypertension  was  reported
y  12.1%  of  patients  and  diabetes  (not  requiring  insulin)  by
.6%.  These  complications  were  not  related  to  weight  gain.
.4.3.  Follow-up
nly  7.7%  of  patients  underwent  post-treatment  polysomno-
raphy,  including  3  simple  snorers  and  3  OSAS  patients.
herefore,  24  patients  with  preoperative  OSAS  (88.8%)  did
ot  have  a  control  recording  after  treatment.
Six  subjects  had  a  complementary  treatment:  3  patients
sed  an  oral  appliance,  2  patients  used  CPAP  and  1  had
elopharyngeal  surgery.
Of  the  77  evaluated  patients,  58  (59.7%)  claimed  they
ould  be  willing  to  undergo  a  second  course  of  RF  treatment
or  their  snoring.
. Discussionadiofrequency  stiffening  and  ablation  of  the  soft  palate
s  now  widely  used  to  treat  snoring,  although  few  con-
rolled  trials  studied  its  efﬁcacy.  Stuck  published  the  only
v
n
i
m70  68.4  0.27
ale; BMI: body mass index; OSA: obstructive sleep apnea.
andomized  placebo-controlled  trial,  which  included  23
atients  with  6  to  8  weeks’  follow-up  [9].  Similarly,  few
tudies  assessed  the  mid-  and  long-term  results  of  this  treat-
ent  or  the  rate  of  symptom  recurrence.  Back  et  al.  studied
1  patients  with  a  mean  follow-up  of  12  months  [5]. Li  et  al.,
6]  and  Said  et  al.,  [7]  respectively  studied  cohorts  of  22
nd  39  patients,  with  a  mean  follow-up  of  14  months.  Only
 prospective  trial  examined  the  long-term  (19.3  months)
esults  of  this  technique,  on  a  cohort  of  19  patients  [8].  To
ur  knowledge,  our  study  has  the  longest  published  follow-
p  time  (6.3  years)  on  a  large  cohort  of  patients  (n  =  77).
All  of  the  above  studies  showed  that  snoring  recurred
fter  RF  treatment.  Recurrence  rates  were  11%  [7], 20%
5],  30%  [10],  37%  [8]  and  41%  [6]. Our  results  also  conﬁrm
his  relapse  over  time,  although  we  found  a  much  higher
ate,  with  92.7%  of  bed-partners  who  reported  a  qualitative
ncrease  in  snoring  intensity  in  the  long  term.  VAS  sco-
ing  showed  a  more  modest  increase:  65.5%  of  bed-partners
eported  a  signiﬁcant  increase.  This  recurrence  rate,  higher
han  previously  reported,  is  probably  the  result  of  our  longer
ollow-up  time.
Some  studies  reported  that  BMI  was  the  main  factor
ffecting  the  short-term  results  of  soft  palate  RF  [10,11].
onsequently,  we  looked  at  weight  gain  as  a  risk  factor
or  snoring  recurrence  [2]. Our  results  did  not  conﬁrm
his  hypothesis  statistically,  although  a  trend  was  observed
owards  it;  one  reason  could  be  that  mean  weight  gain  in  our
opulation  was  mild.  These  results  are  in  agreement  with
hose  published  by  Stuck  et  al.  [8]. Similarly,  we  did  not  ﬁnd
ny  difference  in  recurrence  rates  between  simple  snorers
nd  mild  to  moderate  OSAS  patients.
Our  results  show  that  the  initial  response  to  the  treat-
ent  affects  the  recurrence  rate.  We  observed  that  a
reater  decrease  in  snoring  intensity  in  the  short  term  was
ssociated  with  a greater  risk  of  recurrence  as  measured
ith  the  long-term  VAS.  This  might  not  appear  to  be  logical,
ut  could  possibly  be  explained  by  the  fact  that  greater  vari-
tions  in  sound  intensity  are  more  perceptible  than  minor
nes.  When  snoring  has  been  greatly  decreased  or  com-
letely  suppressed,  a  recurrence  might  be  more  perceptible
han  a  similar  increase  from  a  louder  starting  point.  The
econd  factor  inﬂuencing  recurrence  is  uvulectomy,  which
ppears  to  decrease  the  recurrence  rate.  This  might  be
xplained  by  the  fact  that  the  stiffened  portions  of  the
elum  can  soften  with  time,  whereas  a  shortened  uvula  will
ot  regrow.  Moreover,  even  if  the  uvula  did  not  participate
n  the  vibration  initially,  it  can  become  part  of  the  snoring
echanism  over  time.
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Given  the  good  tolerance  and  low  morbidity  of  the
treatment  in  the  short  term,  a  new  RF  session  could  be  con-
sidered,  especially  as  60%  of  patients  reported  that  they
would  be  ready  to  do  it  again.  Of  course,  the  uvula  should  be
shortened  at  that  time  if  it  had  been  left  intact  previously.
Our  results  show  the  importance  of  informing  patients
about  the  risk  of  recurrence  before  they  undergo  RF  treat-
ment,  even  if  short-term  results  are  favorable.  All  patients
should  be  counseled  about  repeat  polysomnography,  the
need  for  a  long-term  follow-up  and  the  possibility  of  a  sec-
ond  course  of  treatment  in  the  future.  However,  even  in
presence  of  recurrence,  the  snore  sound  intensity  generally
remains  below  the  initial  values.
The  prevalence  of  hypertension  in  our  high-risk  pop-
ulation  increased  from  4.1%  to  12.1%  during  follow-up.
Similarly,  the  proportion  of  subjects  suffering  from  diabetes
went  from  2.7%  to  9.6%,  and  the  Epworth  score  signiﬁcantly
increased.  The  occurrence  of  these  conditions  can  be  the
result  of  onset  of  OSAS  in  simple  snorers  or  of  worsening
when  it  was  already  present.  Only  comparative  random-
ized  studies  will  show  whether  treating  patients  with  simple
snoring  or  mild  to  moderate  sleep-disordered  breathing  can
prevent  them  from  having  cardiovascular  complications  such
as  high  blood  pressure.
In  our  study,  only  7.7%  of  subjects  underwent  post-
treatment  polysomnography.  Almost  90%  of  the  previously
known  OSAS  subjects  were  not  controlled  postoperatively.
Conﬁrming  the  efﬁcacy  of  the  treatment  and  keeping  track
of  these  patients  is  a  difﬁcult  task  but  is  essential.  Our
utmost  attention  should  be  focused  on  improving  the  follow-
up  protocols  for  these  patients.
Our  study  has  limitations.  The  design  was  retrospec-
tive  and  unfortunately  not  a  longitudinal  prospective  study
with  a  non-treated  control  group,  but  this  type  of  study
is  difﬁcult  to  perform  over  such  a  long  period  of  time
and  on  a  large  population,  at  least  in  France.  The  num-
ber  of  excluded  patients  (lost  to  follow-up  +  questionnaires
not  correctly  ﬁlled  out)  was  fairly  high  (46/123)  and  may
have  introduced  biases;  mean  follow-up,  however,  was
longer  than  6  years.  Regarding  the  surgical  technique,  2
types  were  used:  interstitial  radiofrequency,  with  or  with-
out  uvulectomy.  To  perform  these  two  techniques,  several
RF  generators  (with  different  waveforms)  and  electrodes
(monopolar  or  bipolar)  were  used  (as  part  of  a  previous  com-
parative  study)  and  this  may  seem  to  raise  a  methodological
problem;  comparing  4  of  these  different  systems,  however,
as  reported  in  the  previously  published  article,  did  not  ﬁnd
any  difference  in  terms  of  efﬁcacy  [12].  Although  evalua-
tion  at  the  various  time-points  was  performed  with  the  same
tools  and  the  same  bed-partners,  some  factors,  such  as  hear-
ing  levels  or  personal  relationships,  may  have  been  subject
to  evolution.5. Conclusion
Radiofrequency  treatment  of  the  soft  palate  reduces  snoring
in  the  short  term.  We  demonstrated  a  signiﬁcant  recurrence
[31
ate  in  the  long  term,  but  with  a lesser  intensity  than  pre-
peratively.  This  can  be  due  to  softening  of  the  scar  tissue.
ood  initial  results  do  not  guarantee  long-term  results  and
ven  appear  to  inﬂuence  them  negatively.  It  is  therefore
mportant  to  counsel  patients  properly  about  these  issues.
iven  the  good  tolerance  and  low  morbidity  of  RF,  further
essions  can  be  considered  in  order  to  improve  quality  of  life.
n  fact,  most  patients  would  be  willing  to  undergo  further
reatment.  Regarding  follow-up,  few  control  polysomnogra-
hies  were  performed,  although  it  is  essential  to  obtain
bjective  follow-up  measures  to  monitor  a  possible  wors-
ning  of  the  disease  towards  OSAS.  All  patients  must
herefore  be  properly  counseled  about  short  and  long-term
ollow-up.
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